BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 24970670)

  • 1. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves.
    Schwietz T; Behjati S; Gafoor S; Seeger F; Doss M; Sievert H; Zeiher AM; Fichtlscherer S; Lehmann R
    EuroIntervention; 2015 Apr; 10(12):1468-73. PubMed ID: 24970670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The systemic inflammatory response syndrome predicts short-term outcome after transapical transcatheter aortic valve implantation.
    Rettig TC; Rigter S; Nijenhuis VJ; van Kuijk JP; ten Berg JM; Heijmen RH; van de Garde EM; Noordzij PG
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):283-7. PubMed ID: 25649701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study.
    Stähli BE; Grünenfelder J; Jacobs S; Falk V; Landmesser U; Wischnewsky MB; Lüscher TF; Corti R; Maier W; Altwegg LA
    J Invasive Cardiol; 2012 Aug; 24(8):407-11. PubMed ID: 22865312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
    Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
    Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midterm outcomes after transcatheter aortic valve implantation.
    Lotfi S; Dohmen G; Götzenich A; Haushofer M; Spillner JW; Autschbach R; Hoffmann R
    Innovations (Phila); 2014; 9(5):343-7; discussion 348. PubMed ID: 25238419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
    Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study.
    Kahlert P; Al-Rashid F; Döttger P; Mori K; Plicht B; Wendt D; Bergmann L; Kottenberg E; Schlamann M; Mummel P; Holle D; Thielmann M; Jakob HG; Konorza T; Heusch G; Erbel R; Eggebrecht H
    Circulation; 2012 Sep; 126(10):1245-55. PubMed ID: 22899774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches.
    Bona V; Khawaja MZ; Bapat V; Young C; Hancock J; Redwood S; Fusari M; Thomas M
    EuroIntervention; 2015 Jun; 11(2):221-9. PubMed ID: 24769484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation.
    Sinning JM; Scheer AC; Adenauer V; Ghanem A; Hammerstingl C; Schueler R; Müller C; Vasa-Nicotera M; Grube E; Nickenig G; Werner N
    Eur Heart J; 2012 Jun; 33(12):1459-68. PubMed ID: 22285582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes After Transapical and Transfemoral Transcatheter Aortic Valve Insertion: An Evolving Experience.
    Murashita T; Greason KL; Pochettino A; Sandhu GS; Nkomo VT; Bresnahan JF; Reeder GS; Holmes DR; Rihal CS; Mathew V
    Ann Thorac Surg; 2016 Jul; 102(1):56-61. PubMed ID: 27112646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
    Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral versus transapical approach for transcatheter aortic valve implantation: hospital outcome and risk factor analysis.
    Ferrari E; Eeckhout E; Keller S; Muller O; Tozzi P; Berdajs D; von Segesser LK
    J Cardiothorac Surg; 2017 Sep; 12(1):78. PubMed ID: 28874169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Carotid Artery as a Preferred Alternative Access Route for Transcatheter Aortic Valve Replacement.
    Kirker EB; Hodson RW; Spinelli KJ; Korngold EC
    Ann Thorac Surg; 2017 Aug; 104(2):621-629. PubMed ID: 28274520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.
    van der Boon RM; Marcheix B; Tchetche D; Chieffo A; Van Mieghem NM; Dumonteil N; Vahdat O; Maisano F; Serruys PW; Kappetein AP; Fajadet J; Colombo A; Carrié D; van Domburg RT; de Jaegere PP
    Ann Thorac Surg; 2014 Jan; 97(1):22-8. PubMed ID: 24263012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation].
    Bartoli S; Saia F; Marrozzini C; Berti E; Guastaroba P; Fortuna D; Ciuca C; Moretti C; Marzocchi A; De Palma R
    G Ital Cardiol (Rome); 2012 Jan; 13(1):50-8. PubMed ID: 22322472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional left ventricular function after transapical vs. transfemoral transcatheter aortic valve implantation analysed by cardiac magnetic resonance feature tracking.
    Meyer CG; Frick M; Lotfi S; Altiok E; Koos R; Kirschfink A; Lehrke M; Autschbach R; Hoffmann R
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1168-76. PubMed ID: 24906997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.